Clinical Trials Browser

Phase 1/2 × Advanced Malignancies × Clear all

NCT04837196 2025-08-08

Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen

Phase 1/2 Completed

24 enrolled 47 charts

Advanced Malignancies

NCT03907969 2024-02-06

A Clinical Trial to Evaluate AZD7648 Alone and in Combination With Other Anti-cancer Agents in Patients With Advanced Cancers.

Phase 1/2 Completed

30 enrolled 17 charts

Advanced Malignancies

NCT01079702 2010-03-03

m-TOR

Phase 1/2 Unknown

Advanced Malignancies